BRIEF-Tarsus Pharmaceuticals Q2 EPS USD -0.48

Reuters
Aug 07
BRIEF-Tarsus Pharmaceuticals <a href="https://laohu8.com/S/QTWO">Q2</a> EPS USD -0.48

Aug 06 (Reuters) - Tarsus Pharmaceuticals Q2 revenue USD 102.66 million vs. IBES estimate USD 95.7 million.

  • Q2 net income USD -20.34 million
  • Q2 basic EPS USD -0.48
  • Q2 operating expenses USD 124.844 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10